Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL

Clinical trial NCT07250087 · RECRUITING

Trial details

NCT number

NCT07250087

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2026-01-21

Primary completion

2029-11-01

Enrollment

36

View on ClinicalTrials.gov